Lilly CEO Dave Ricks is confident in the ability of the company's pill to compete and is preparing for a "full launch" in the second quarter.
The new World Health Organization guideline supports using GLP-1 drugs for long-term obesity care, emphasizing lifestyle, behavioral therapy.
In an interview with BioPharma Dive, the veteran biotech CEO said there remains a “significant opportunity” for young ...
Sept. 20, 2004 — Editor's Note: At the Second Annual Conference on Legal Approaches to the Obesity Epidemic, held from Sept. 17-19 at Northeastern University School of Law in Boston, Massachusetts, ...
9don MSN
What obesity drugmakers see next in the market: More pills, easier access and drug combinations
CNBC spoke to executives from Eli Lilly, Novo Nordisk, Pfizer and other drugmakers at the annual JPMorgan Healthcare ...
Oprah Winfrey has gone through a noticeable weight loss transformation, but in a new, informative interview, she revealed she ...
WILMINGTON, N.C. (WECT) - Dr. Jayme Stokes, a bariatric surgeon with Novant Health, was in the studio to answer questions about obesity and weight loss options. Dr. Stokes says many factors can cause ...
10don MSN
Healthy returns: Structure Therapeutics CEO on its obesity pill, combinations and future of GLP-1s
Structure Therapeutics CEO Ray Stevens talked about the biotech’s path forward and his expectations for the future of the ...
Queen Latifah wants the world to know obesity is a disease, one often tainted with stigma. The Grammy Award-winning musician and actress opened up about the public awareness campaign, Truth About ...
The obesity grading system involves dividing obesity into three main groups. It uses your body mass index (BMI), which is a ratio of weight to height, to categorize your level of obesity. Doctors ...
According to the National Family Health Survey (NFHS) 2019–21, nearly one in four Indian adults is overweight or obese, with 24% of women and 23% of men affected. Childhood obesity has also risen ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results